Academic Journal
The effects of prolactin receptor blockade in a murine endometriosis interna model
| العنوان: | The effects of prolactin receptor blockade in a murine endometriosis interna model |
|---|---|
| المؤلفون: | Christiane Otto, Hannes‐Friedrich Ulbrich, Christoph Freiberg |
| المصدر: | Pharmacology Research & Perspectives, Vol 10, Iss 1, Pp n/a-n/a (2022) |
| بيانات النشر: | Wiley, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Therapeutics. Pharmacology |
| مصطلحات موضوعية: | endometriosis, murine endometriosis interna model, prolactin, prolactin receptor antibody, Therapeutics. Pharmacology, RM1-950 |
| الوصف: | Abstract Endometriosis in an estrogen‐dependent disease that is characterized by the presence of endometrial tissue outside the uterine cavity leading to pain and infertility in many affected women. Highly efficient treatment options which create a hypo‐estrogenic environment can cause side effects such as hot flushes and bone mass loss that are not favorable for premenopausal women. Previous work has demonstrated that increased local or systemic prolactin seems to be involved in the pathogenesis of endometriosis. Here we examined two prolactin receptor (PRLR) blocking antibodies in a murine endometriosis interna model which relies on the induction of systemic hyperprolactinemia in female SHN mice. The severity of the disease is determined by the degree of endometrial invasion into the myometrium. In this model, endometriosis was inhibited by clinical gold standards such as progestins and anti‐estrogenic approaches. PRLR blockade completely inhibited endometriosis in this mouse model to the same extent as the anti‐estrogen faslodex or the GnRH antagonist cetrorelix. In contrast to cetrorelix and faslodex, the PRLR antibodies did not decrease relative uterine weights and were thus devoid of anti‐estrogenic effects. We therefore hypothesize that PRLR antibodies may present a novel and highly efficient treatment option for endometriosis with a good safety and tolerability profile. Clinical studies are on the way to test this hypothesis. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2052-1707 |
| Relation: | https://doaj.org/toc/2052-1707 |
| DOI: | 10.1002/prp2.916 |
| URL الوصول: | https://doaj.org/article/7e398b98b55e49dc9c58f897d006d766 |
| رقم الانضمام: | edsdoj.7e398b98b55e49dc9c58f897d006d766 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | ResultId |
1 |
|---|---|
| Header |
edsdoj Directory of Open Access Journals edsdoj.7e398b98b55e49dc9c58f897d006d766 938 3 Academic Journal academicJournal 937.612426757813 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.7e398b98b55e49dc9c58f897d006d766&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doaj.org/article/7e398b98b55e49dc9c58f897d006d766 [Name] => EDS - DOAJ [Category] => fullText [Text] => View record in DOAJ [MouseOverText] => View record in DOAJ ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsdoj&genre=article&issn=20521707&ISBN=&volume=10&issue=1&date=20220201&spage=&pages=&title=Pharmacology Research & Perspectives&atitle=The%20effects%20of%20prolactin%20receptor%20blockade%20in%20a%20murine%20endometriosis%20interna%20model&id=DOI:10.1002/prp2.916 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => The effects of prolactin receptor blockade in a murine endometriosis interna model
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Christiane+Otto%22">Christiane Otto</searchLink><br /><searchLink fieldCode="AR" term="%22Hannes‐Friedrich+Ulbrich%22">Hannes‐Friedrich Ulbrich</searchLink><br /><searchLink fieldCode="AR" term="%22Christoph+Freiberg%22">Christoph Freiberg</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Pharmacology Research & Perspectives, Vol 10, Iss 1, Pp n/a-n/a (2022) ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Wiley, 2022. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2022 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => LCC:Therapeutics. Pharmacology ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22endometriosis%22">endometriosis</searchLink><br /><searchLink fieldCode="DE" term="%22murine+endometriosis+interna+model%22">murine endometriosis interna model</searchLink><br /><searchLink fieldCode="DE" term="%22prolactin%22">prolactin</searchLink><br /><searchLink fieldCode="DE" term="%22prolactin+receptor+antibody%22">prolactin receptor antibody</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%2E+Pharmacology%22">Therapeutics. Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22RM1-950%22">RM1-950</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Abstract Endometriosis in an estrogen‐dependent disease that is characterized by the presence of endometrial tissue outside the uterine cavity leading to pain and infertility in many affected women. Highly efficient treatment options which create a hypo‐estrogenic environment can cause side effects such as hot flushes and bone mass loss that are not favorable for premenopausal women. Previous work has demonstrated that increased local or systemic prolactin seems to be involved in the pathogenesis of endometriosis. Here we examined two prolactin receptor (PRLR) blocking antibodies in a murine endometriosis interna model which relies on the induction of systemic hyperprolactinemia in female SHN mice. The severity of the disease is determined by the degree of endometrial invasion into the myometrium. In this model, endometriosis was inhibited by clinical gold standards such as progestins and anti‐estrogenic approaches. PRLR blockade completely inhibited endometriosis in this mouse model to the same extent as the anti‐estrogen faslodex or the GnRH antagonist cetrorelix. In contrast to cetrorelix and faslodex, the PRLR antibodies did not decrease relative uterine weights and were thus devoid of anti‐estrogenic effects. We therefore hypothesize that PRLR antibodies may present a novel and highly efficient treatment option for endometriosis with a good safety and tolerability profile. Clinical studies are on the way to test this hypothesis. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => electronic resource ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 2052-1707 ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://doaj.org/toc/2052-1707 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1002/prp2.916 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://doaj.org/article/7e398b98b55e49dc9c58f897d006d766" linkWindow="_blank">https://doaj.org/article/7e398b98b55e49dc9c58f897d006d766</link> ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsdoj.7e398b98b55e49dc9c58f897d006d766 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1002/prp2.916
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => endometriosis
[Type] => general
)
[1] => Array
(
[SubjectFull] => murine endometriosis interna model
[Type] => general
)
[2] => Array
(
[SubjectFull] => prolactin
[Type] => general
)
[3] => Array
(
[SubjectFull] => prolactin receptor antibody
[Type] => general
)
[4] => Array
(
[SubjectFull] => Therapeutics. Pharmacology
[Type] => general
)
[5] => Array
(
[SubjectFull] => RM1-950
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => The effects of prolactin receptor blockade in a murine endometriosis interna model
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Christiane Otto
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hannes‐Friedrich Ulbrich
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Christoph Freiberg
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 02
[Type] => published
[Y] => 2022
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 20521707
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 10
)
[1] => Array
(
[Type] => issue
[Value] => 1
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Pharmacology Research & Perspectives
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |